Sentences with phrase «promise of embryonic stem cell»

Prop. 71 was sold to voters mainly on the promise of embryonic stem cell therapy.

Not exact matches

Let us be thankful that a tool for discrediting the pro-life movement (shaming us for opposing magical cures promised by embryonic stem - cell research) has itself been taken out of their hands.

The year's most prominent science issue, federal support of embryonic stem cell research, is so controversial that the sons of Ronald Reagan gave dueling speeches at the opposing party conventions; Michael Reagan backs President George W. Bush's policies, including the ban on funding for research on new stem cell lines, while Ron supports Senator John Kerry's promise to lift restrictions.

In the past few months, researchers in the United States and Japan have described a promising way of deriving embryonic stem cells from skin cells (of mice) without destroying embryos — the «Holy Grail of biotechnology,» as The Times of London put it.

Others trumpeted «alternative» techniques that promise the creation of embryonic stem cells without destroying embryos.

Both Obama and Clinton voted against the Hope Act and many stem cell research supporters have criticized the bill, saying it's a distraction and diversion of funds away from the greater promise of embryonic cells.

There is promising news today for those who hope to turn the potential of undifferentiated stem cells into medical miracles: Researchers are reporting a way to produce insulin - producing cells from mouse embryonic stem cells.

This insight provides new avenues for improving the quality and stability of embryonic stem cells — an essential requirement to fulfil their promise in regenerative medicine.

First, promising to restore the integrity of science while seeking vast medical benefits for many, President Obama repealed the restrictions set by President Bush on the use of federal funds for embryonic stem cell research.

But for well over a decade now, ethically contentious human embryonic stem cell research (hESCR) has notably failed to live up to all its hype, with promises of miracle cures within «five to 10 years» remaining unfulfilled.

Diabetes has long been one of the main diseases for which human embryonic stem cell (embryo - destroying) research, or hESCR, was claimed to hold the greatest promise of curing.

And while there are now fewer obstacles impeding embryonic stem cell research, the promise of iPS cells has taken them beyond ethical considerations.

Despite the promise of iPS cells, scientists are still struggling to understand whether their developmental potential is equivalent to that of embryonic stem cells.

The excitement surrounding cellular reprogramming and the possibility of federal funding for human embryonic stem cell (ESC) research in the US could be overshadowing another promising therapeutic source of stem cells: those derived via parthenogenesis, some researchers say.

Their promise was so great that when President Obama announced last March that he was lifting the ban on the use of federal money for research on human embryonic stem cells, critics on the right were apoplectic: iPS cells, they said, made such a move scientifically unjustified.

The discovery, by scientists at Kyoto University and the University of Wisconsin - Madison, seemed to promise a way out of the bitter debates over embryonic - stem - cell research: rather than using human embryos as a source of stem cells, produce them from adult cells.

In 2004, this editorial page backed Proposition 71, a $ 3 billion ballot measure meant to bypass then - President George W. Bush's ban on human embryonic stem cell research and to put California in the forefront of this hugely promising field.

Jang has conducted research with embryonic stem cells in the past, but she and others are finding great promise in another kind of stem cell called induced pluripotent stem cells, or iPS cells.

The NIH announced in the Federal Register on Tuesday that it plans to tweak its stem cell guidelines in order to accept a wider array of scientifically promising human embryonic stem cells.

But even before the cash spigot opens, the government may close it — or even try to limit research on human embryonic stem cells, the more promising and controversial type of stem cell.

Washington — Leaders of a congressional effort to boost embryonic stem - cell research will huddle soon to develop strategies for passing their bill around President Bush's promised veto.

Embryonic stem cells — «pluripotent» cells that can develop into any type of cell in the human body — hold tremendous promise for regenerative medicine, in which damaged organs and tissues can be replaced or repaired.

However welcome the recent announcement that a team of scientists based at Newcastle University, has grown a section of human liver using stem cells from umbilical cords, rather than from the more controversial source of embryonic stem cells, and whatever the eventual promise or potential of harvesting organs for transplantation from genetically modified pigs, the benefits of either of these two pioneering techniques to currently dying / suffering patients, remain both elusive and distant.